Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$1.8 - $7.49 $148,199 - $616,674
-82,333 Closed
0 $0
Q2 2023

Aug 14, 2023

SELL
$4.3 - $9.48 $1.38 Million - $3.04 Million
-321,116 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$4.81 - $8.88 $192,015 - $354,489
39,920 New
39,920 $247,000
Q4 2022

Feb 14, 2023

BUY
$6.52 - $8.05 $260,278 - $321,356
39,920 New
39,920 $285,000
Q3 2022

Nov 13, 2023

BUY
$7.57 - $12.5 $623,260 - $1.03 Million
82,333 New
82,333 $637,000
Q2 2022

Aug 14, 2023

BUY
$5.04 - $9.48 $1.62 Million - $3.04 Million
321,116 New
321,116 $2.45 Million
Q1 2022

May 12, 2023

BUY
$7.09 - $89.45 $3.38 Million - $42.7 Million
477,296 Added 1195.63%
517,216 $3.99 Million
Q1 2022

May 09, 2022

SELL
$7.09 - $89.45 $1.95 Million - $24.6 Million
-274,816 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$80.85 - $128.49 $22.2 Million - $35.3 Million
274,816 New
274,816 $23.3 Million
Q3 2021

Nov 14, 2022

BUY
$81.97 - $106.94 $23.6 Million - $30.8 Million
288,216 New
288,216 $27.7 Million
Q3 2021

Nov 05, 2021

SELL
$81.97 - $106.94 $15.5 Million - $20.3 Million
-189,457 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$77.2 - $126.54 $14.6 Million - $24 Million
189,457 New
189,457 $17.6 Million
Q2 2021

Aug 10, 2021

SELL
$77.2 - $126.54 $24 Million - $39.3 Million
-310,916 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$110.45 - $164.47 $34.3 Million - $51.1 Million
310,916 New
310,916 $35.3 Million
Q1 2021

May 07, 2021

SELL
$110.45 - $164.47 $42.1 Million - $62.7 Million
-381,469 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$60.78 - $154.03 $23.2 Million - $58.8 Million
381,469 New
381,469 $56 Million
Q4 2020

Feb 10, 2021

SELL
$60.78 - $154.03 $23.5 Million - $59.5 Million
-386,411 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$45.05 - $59.27 $17.4 Million - $22.9 Million
386,411 New
386,411 $22.9 Million
Q3 2020

Nov 10, 2020

SELL
$45.05 - $59.27 $15.9 Million - $20.9 Million
-351,925 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$42.74 - $66.25 $15 Million - $23.3 Million
351,925 New
351,925 $19 Million
Q2 2020

Aug 07, 2020

SELL
$42.74 - $66.25 $14.8 Million - $22.9 Million
-345,622 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$38.18 - $73.95 $13.2 Million - $25.6 Million
345,622 New
345,622 $16.5 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.